Sign in
Active, not recruitingEarly phase 1

Effect of Addition of Steroids on Duration of Analgesia

Key facts

Who runs it
University of California, Los Angeles
Where
Chapel Hill and Westwood, Los Angeles, United StatesSee the 2 sites
Trial code
Status
Active, not recruiting
Phase
Early phase 1
People taking part
28 people enrolled
Started
6 Jan 2022
Expected to end
2 Aug 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Triamcinolone
  • Bupivacaine
  • Iohexol contrast
Record updated
12 November 2026

Who can take part

Age
30 years to 60 years
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • females
  • aged between 30 and 60 years
  • diagnosed with symptomatic uterine fibroids and/or adenomyosis and scheduled to undergo UAE procedure

Who cannot take part

  • Allergies to local anesthetic or steroid agent
  • History of inflammatory bowel disease or ulcerative colitis
  • Diabetes mellitus
  • Contraindications to UAE
  • SHNB is deemed unsafe for the patient
  • Uncorrectable abnormal coagulation profile

Where in United States

  • University of North CarolinaChapel Hill, United States
  • University of California, Los AngelesWestwood, Los Angeles, United States

About the trial

What the trial wants to find out

The purpose of the study is to investigate the differences in post-procedural pain scores and narcotic use among patients who receive a Superior Hypogastric Nerve Block (SHNB) with and without corticosteroid performed as part of the Uterine Artery Embolization (UAE) procedure.

The 2 groups in the trial

  • BupivacaineExisting treatment, for comparison

    During the Uterine Artery Embolization (UAE) procedure, participants in this arm receive bupivacaine and contrast to enable visualization of the nerve block under fluoroscopy.

    Treatment: Bupivacaine and Iohexol contrast

  • Bupivacaine and TriamcinoloneTreatment being tested

    During the Uterine Artery Embolization (UAE) procedure, participants in this arm receive bupivacaine plus triamcinolone mixed with contrast to enable visualization of the nerve block under fluoroscopy.

    Treatment: Triamcinolone, Bupivacaine, and Iohexol contrast

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective Randomized Controlled Clinical Trial: Superior Hypogastric Nerve Block for Pain Control After Uterine Artery Embolization: Effect of Addition of Steroids on Duration of Analgesia
Record updated
12 November 2026